Heartburn Agony Ends: New Implant a Game Changer

Sally Ann Warner, 64, endured a harrowing 22-year battle with severe acid reflux, a condition medically known as gastroesophageal reflux disease (GORD). Her ordeal began in 2003 with a seemingly innocuous holiday drink that triggered a cascade of agonizing symptoms, including waking up to yellow bile pouring from her nose. This chronic condition significantly impacted her health, sleep, and overall well-being, forcing her to sleep in a separate room from her husband.

Initially, Warner was prescribed proton pump inhibitors (PPIs), a common medication for acid reduction. However, these drugs provided only temporary relief and raised concerns due to potential long-term health risks, such as bone health issues and increased infection susceptibility. Standard surgical options like fundoplication also seemed unappealing due to their restrictive nature, preventing natural bodily functions like burping.

A significant turning point occurred when her son discovered RefluxStop, a minimally invasive procedure offered at St. Mary's Hospital in London. This novel implant, fitted via keyhole surgery, restores the lower esophageal sphincter to its natural position, effectively preventing acid reflux without hindering natural functions. Warner underwent the procedure in July 2025 and has since experienced complete relief, able to enjoy foods and drinks that previously caused immense discomfort.

The RefluxStop device, smaller than a ping-pong ball, has been adopted by some NHS trusts, with University Hospital Southampton also offering it since 2024. While not yet a routine NHS operation and costing between £11,000 and £16,000 privately, it represents a significant advancement in treating GORD. Patients experiencing similar long-term suffering are advised to consult a GP for a referral to a specialized Upper Gastrointestinal Surgeon.